2022-02-01
Midas' API "Crotamiton" has been successfully approved in China
Midas is currently supplying the only imported Crotamiton API approved in China and meantime with a CEP certificate. Its registration status in the CDE (CENTER FOR DRUG EVALUATION) has been shown as "A (Active)". Customers who need to use Crotamiton as a raw material for R&D and production can use it with confidence.
Use of Crotamiton:
Crotamiton acts on the nervous system of scabies and kills it. In addition, it has a mild local anesthetic effect that relieves itching. It can be used as raw material or excipients in the pharmaceutical industry. The main dosage forms are among others creams and gel patches.
For more details, please contact us.
Your Contact
Thorsten Schäfer
International Division
Chairman
Midas Pharma GmbH
Rheinstr. 49
55218 Ingelheim
Germany
Rheinstr. 49
55218 Ingelheim
Germany